Main caricature of Kristen Fortney, who is speaking at HLTH and is CEO at BIOAGE Overlay caricature of Kristen Fortney, who is speaking at HLTH and is CEO at BIOAGE

Kristen Fortney

CEO

BIOAGE

Kristen leads BIOAGE in its mission to develop a broad pipeline of therapies that target aging in order to increase healthspan and address chronic diseases. Kristen draws from a deep background in aging research and systems biology to develop BIOAGE’s data-driven approach to identify and target the molecular pathways that drive aging. Kristen received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University where she was a fellow of the Ellison Medical Foundation / American Federation for Aging Research. She has over 10 years of experience developing novel bioinformatics approaches for data-driven investigation into the mechanisms of aging and age-related disease, with 18 published papers spanning computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.

See All Speakers

Some additional speakers you may like

Chief Digital & Technology Officer
GSK
Chief Marketing Officer
Hims & Hers
Senior Advisor to the Secretary and Deputy Administrator of CMS and Director of the CMS Innovation Center
Center for Medicare and Medicaid Innovation
President and Chief Executive Officer
Highmark Health